Prognostic value of plasma MR-proADM vs NT-proBNP for heart failure in people with type 2 diabetes: the SURDIAGENE prospective study

被引：0

作者：

Mathilde Fraty

Gilberto Velho

Elise Gand

Fréderic Fumeron

Stéphanie Ragot

Philippe Sosner

Kamel Mohammedi

Barnabas Gellen

Pierre-Jean Saulnier

Jean-Michel Halimi

David Montaigne

Grégory Ducrocq

Michaela Rehman

Michel Marre

Ronan Roussel

Samy Hadjadj

机构：

[1] CHU de Poitiers,Centre d’Investigation Clinique

[2] CHU de Poitiers,Service d’Endocrinologie

[3] Centre de Recherche des Cordeliers,Diabétologie

[4] Inserm UMR_S 1138,Pole DUNE (Digestif, Urologie, Néphrologie, Endocrinologie)

[5] CHU de Poitiers,Laboratoire MOVE (EA 6314), Faculté des Sciences du Sport

[6] UFR de Médecine,Service de Cardiologie

[7] Université Paris Diderot,Service Néphrologie, Dialyse et Transplantation

[8] Sorbonne Paris Cité,Clinique de Physiologie et Département d’Échocardiographie

[9] UFR de Médecine et Pharmacie,Service de Cardiologie

[10] Université de Poitiers,undefined

[11] CIC 1402,undefined

[12] Inserm Poitiers,undefined

[13] Centre médico-sportif MON STADE,undefined

[14] Centre de Diagnostic et de Thérapeutique,undefined

[15] AP-HP Hôpital Universitaire Hôtel-Dieu,undefined

[16] Université de Poitiers,undefined

[17] Service Endocrinologie,undefined

[18] Diabétologie,undefined

[19] Nutrition,undefined

[20] Hôpital Haut Lévêque,undefined

[21] CHU de Bordeaux,undefined

[22] Polyclinique de Poitiers,undefined

[23] CHU de Tours,undefined

[24] Inserm CIC0202,undefined

[25] CHRU Lille,undefined

[26] Inserm U1011,undefined

[27] EGID,undefined

[28] Institut Pasteur de Lille,undefined

[29] Université de Lille,undefined

[30] Service de Cardiologie,undefined

[31] AP-HP,undefined

[32] Hôpital Bichat Claude Bernard,undefined

[33] CHU de Poitiers,undefined

[34] Service de Diabétologie,undefined

[35] Endocrinologie et Nutrition,undefined

[36] DHU FIRE,undefined

[37] AP-HP,undefined

[38] Hôpital Bichat Claude Bernard,undefined

来源：

Diabetologia | 2018年 / 61卷

关键词：

Adrenomedullin; Biomarkers; BNP; Heart failure; NT-proBNP; Prognosis; Type 2 diabetes;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：2643 / 2653

页数：10

共 50 条

[31] Limited value of NT-proBNP as a prognostic marker of all-cause mortality in patients with heart failure with preserved and mid-range ejection fraction in primary care: A report from the swedish heart failure register
Eriksson, Bjorn
Wandell, Per
Dahlstrom, Ulf
Nasman, Per
Lund, Lars H.
Edner, Magnus
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2019, 37 (04) : 434 - 443
[32] The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T
Metra, Marco
Nodari, Savina
Parrinello, Giovanni
Specchia, Claudia
Brentana, Loretta
Rocca, Patrizia
FracasSi, Francesco
Bordonall, Tania
Milani, Patrizia
DaneSi, Rossella
Verzura, Giulia
Chiari, Ermanna
Cas, Livio Dei
EUROPEAN JOURNAL OF HEART FAILURE, 2007, 9 (08) : 776 - 786
[33] Comparison of predictive value of NT-proBNP, sST2 and MMPs in heart failure patients with different ejection fractions
Pan, Wei
Yang, Donghui
Yu, Peng
Yu, Huizhen
BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)
[34] Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure
Vergaro, Giuseppe
Gentile, Francesco
Aimo, Alberto
Januzzi, James L.
Richards, A. Mark
Lam, Carolyn S. P.
Boer, Rudolf A.
Meems, Laura M. G.
Latini, Roberto
Staszewsky, Lidia
Anand, Inder S.
Cohn, Jay N.
Ueland, Thor
Gullestad, Lars
Aukrust, Pal
Rocca, Hans-Peter Brunner-La
Bayes-Genis, Antoni
Lupon, Josep
Yoshihisa, Akiomi
Takeishi, Yasuchika
Egstrup, Michael
Gustafsson, Ida
Gaggin, Hanna K.
Eggers, Kai M.
Huber, Kurt
Gamble, Greg D.
Ling, Lieng H.
Leong, Kui Toh Gerard
Yeo, Poh Shuah Daniel
Ong, Hean Yee
Jaufeerally, Fazlur
Ng, Tze P.
Troughton, Richard
Doughty, Robert N.
Devlin, Gerry
Lund, Mayanna
Giannoni, Alberto
Passino, Claudio
Emdin, Michele
ESC HEART FAILURE, 2022, 9 (04): : 2084 - 2095
[35] Superior prognostic value of soluble suppression of tumorigenicity 2 for the short-term mortality of maintenance hemodialysis patients compared with NT-proBNP: a prospective cohort study
Wang, Zhiyu
Chen, Zijin
Yu, Haijin
Ma, Xiaobo
Zhang, Chunli
Qu, Bin
Zhang, Wen
Chen, Xiaonong
RENAL FAILURE, 2020, 42 (01) : 523 - 530
[36] Maximum longitudinal relaxation velocity of the left ventricle:: Its clinical value and relationship with NT-proBNP plasma levels in heart failure
Taléns-Visconti, R
Rivera, M
Climent, V
Valero, R
Martínez-Dolz, L
Sancho-Tello, MJ
Cortés, R
Miro, V
Sevilla, B
Perez-Bosca, JL
Bertomeu, V
Salvador, A
Jordan, A
Marin, F
Sogorb, F
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2006, 23 (04): : 295 - 302
[37] Prognostic significance of NT-proBNP and sST2 in patients with heart failure with preserved and mildly reduced ejection fraction
Podzolkov, V., I
Dragomiretskaya, N. A.
Tolmacheva, A., V
Shvedov, I. I.
Ivannikov, A. A.
Yu, Akyol, V
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2023, 19 (04) : 310 - 319
[38] Prediction of congestive state in acute and chronic heart failure: The association between NT-proBNP and left atrial strain and its prognostic value
Pastore, Maria Concetta
Mandoli, Giulia Elena
Stefanini, Andrea
Ghionzoli, Nicolo
Carrucola, Chiara
De Carli, Giuseppe
Lisi, Matteo
Cavigli, Luna
D'Ascenzi, Flavio
Focardi, Marta
Valente, Serafina
Patti, Giuseppe
Mondillo, Sergio
Cameli, Matteo
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 371 : 266 - 272
[39] Prognostic value of the inferior vena cava diameter, lung ultrasound, and the NT-proBNP level in patients with acute decompensated heart failure and obesity
Kobalava, Zh D.
Montoya, Cabello F. E.
Safarova, A. F.
Tolkacheva, V. V.
Abramov, A. A.
BYULLETEN SIBIRSKOY MEDITSINY, 2023, 22 (01): : 33 - 40
[40] Comparison of predictive value of NT-proBNP, sST2 and MMPs in heart failure patients with different ejection fractions
Wei Pan
Donghui Yang
Peng Yu
Huizhen Yu
BMC Cardiovascular Disorders, 20

← 1 2 3 4 5 →